Avotaciclib (BEY1107) 是一种有效和具有口服活性的 cyclin dependent kinase 1 (CDK1) 抑制剂。Avotaciclib 可用于局部晚期或转移性胰腺癌的研究。
| Cas No. | 1983983-41-0 |
| 别名 | BEY1107 |
| 分子式 | C13H11N7O |
| 分子量 | 281.27 |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Avotaciclib (BEY1107) is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib can be used for the research of locally advanced or metastatic pancreatic cancer[1]. [1]. Seufferlein T, et, al. Phase I Trials in Pancreatic Cancer. Translational Pancreatic Cancer Research pp 219-232. |
